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Context: Many breast cancer patients have unmet informational and psychosocial needs after 
treatment completion. A psycho-educational intervention may be well-suited to support these 
patients.  
Objectives: The purpose of this multicenter randomized controlled trial was to examine the 
effectiveness of a web-based tailored psycho-educational program (ENCOURAGE) for breast 
cancer patients which aims to empower patients to take control over prevailing problems. 
Methods: Female breast cancer patients from two hospitals in the Netherlands who recently 
completed (neo-)adjuvant chemotherapy were randomly assigned to standard care or 12-week 
access to the ENCOURAGE program providing fully automated information, problem-
solving strategies, resources and services for reported problems. At 6 and 12 weeks, patients 
completed self-report questions on optimism and control over the future (primary outcome), 
feelings of being informed and acceptance of the illness. At baseline and 12 weeks, distress 
and quality of life questionnaires were completed.  
Results: 138 patients were included. Almost all patients (67/69) visited ENCOURAGE as 
requested. No differences between the control and the intervention group were observed for 
primary and secondary outcomes. An unplanned subgroup analysis showed that in clinically 
distressed patients (N=57 at baseline; 41%), use of the ENCOURAGE program increased 
optimism and control over the future at 12 weeks more than in patients in the control group 
(Cohen’s d=0.65). 
Conclusions: Although the effectiveness was not demonstrated, a subgroup of women treated 
for breast cancer can probably be supported by the program. The results of the current study 
are a starting point for further development and use of the program. 
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The presence of psychosocial and physical symptoms after completion of breast cancer 
treatment is well-known [1-3]. Patients struggle with psychological issues as well as physical 
symptoms [4,5]. Many patients wish for information about symptoms/problems that may arise 
after treatment completion and about strategies how to cope with these problems [1,6]. 
However, interventions that focus on supporting breast cancer patients during the first year 
after primary treatment completion (i.e. re-entry phase) are scarce [7-9]. Psycho-education, 
which combines patient education with activities such as advice on self-management 
strategies and/or counseling [10,11], may be well-suited to support patients during the re-
entry phase. The few psycho-educational interventions that focused on breast cancer patients 
in the re-entry phase - delivered in multi-sessions via group, face-to-face and/or video format 
- showed positive effects on outcomes such as anxiety, depression, fatigue and quality of life 
[12-14]. Benefits were also found for a brief 2-hour psycho-educational group session 
regarding knowledge and preparedness for the re-entry phase [8]. These interventions 
required involvement of (a) health care professional(s) and, therefore, were relatively labor 
intensive. Considering the growing number of breast cancer survivors, the internet has been 
viewed as a cost-effective medium to support patients [15]. New web-based programs emerge 
at a rapid pace [16], but only few web-based interventions for breast cancer patients in the re-
entry phase are available at present. 
Therefore, we developed the ENCOURAGE program. This is a web-based tailored 
psycho-educational program for breast cancer patients in the re-entry phase which aims to 
empower patients to take control over prevailing problems and to adjust to life after treatment. 
We adopted a problem-solving orientation in the development of ENCOURAGE. This 
orientation involves appraising problems as challenges, be optimistic about the solvability of 
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theory of problem solving, when patients learn to identify and solve problems, their sense of 
control and confidence will increase and these changes will in turn enhance adjustment 
[18,19]. Additionally, research showed that the use of active approach-oriented coping 
strategies (e.g. emotional expression, seeking social support) is related to perceived control 
and enhances healthy adjustment to cancer [20-24]. The possible solutions to a problem 
offered by ENCOURAGE emphasize the use of approach-oriented coping strategies. 
A randomized prospective study was performed to measure the effects of the 
ENCOURAGE program. We hypothesized that breast cancer patients who use the program 
report a larger increase in optimism and feelings of control over the future than patients who 
receive standard care. Patients’ feelings of being informed, acceptance of the illness, distress 
and quality of life were also studied. 
 
METHODS            
Patients 
Patients were recruited at the outpatient clinics of Medical Oncology Departments between 
January 2013 and October 2014 in two hospitals in the North-Eastern part of the 
Netherlands: the Martini Hospital (MH, Groningen) and the University Medical Center 
Groningen (UMCG, Groningen). The study was approved by the medical ethical committee 
and was registered (ClinicalTrials.gov, Identifier NCT01834521). Informed consent was 
obtained from all included patients. Female breast cancer patients diagnosed with primary 
breast cancer who completed curative-intent primary treatment within the past 6 
months (defined as surgery combined with any type of (neo)adjuvant chemotherapy) 
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Other inclusion criteria were: ≥18 years of age, ability to comprehend Dutch reading and 
writing, having access to the internet including an e-mail address (at home or via 
family/friends) and physically and cognitively able to participate. Patients were not eligible 
when they were diagnosed with recurrent and/or metastasized breast cancer. 
  
Procedures 
This was a prospective, randomized controlled, multi-center, parallel-group study. Patients 
who were identified as eligible received a study information letter, an informed consent form, 
the baseline questionnaire (T0), an address form, two general information leaflets (‘Breast 
cancer’ and ‘Continuing life after cancer’ of the Dutch Cancer Society) and a prepaid return 
envelope. Patients who did not return the documents within two weeks received a reminder 
call.    
After receiving the returned documents, patients were randomized between standard 
care (control group) or access to the ENCOURAGE program (intervention group) by a data-
manager of the UMCG. The patients were allocated with a computer-generated randomization 
list using blocked randomization to conceal the allocation sequence until intervention 
assignment (allocation ratio 1:1; block size of 4; stratified per hospital). Patients were 
informed by phone by the research psychologist about the randomization outcome. Blinding 
of patients or the research team was not applied. 
Patients received questionnaires at 6 (T1) and 12 weeks (T2) by mail. If questionnaires 
were not returned after 1 week, patients received a reminder e-mail. Patients were contacted 
by telephone if they did not respond within 1 week after the reminder.  
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Key features of ENCOURAGE (http://lastmeter.medischeoncologiegroningen.nl; username: 
JPainSymptomManage; password: Symptom1; Appendix 1) were inspired on problem-
solving therapy [17,18]: 1) Problem orientation and identification: an online version of the 
Dutch Distress Thermometer (DT) and accompanying 47-item Problem List (PL) covering 
practical, family/social, emotional, religious/spiritual and physical problems [25] was used to 
identify the problems patients experienced. After completion, patients immediately received 
online feedback about their distress score. The feedback identified three levels of distress 
severity (DT=0-4 for no or mild distress; DT=5-7 moderate distress and DT=8-10 severe 
distress [25]); 2) Subsequently, patients received fully automated tailored psycho-education 
for the reported problems. Psycho-educational material was written for 30 problems 
separately, from a re-entry specific viewpoint (Appendix 2). Psycho-education comprised 
background information about problems (including normalization), possible problem-
solving strategies for coping, resources including hyperlinks to other websites and services 
(for self-referral). Completed DT/PL’s were automatically saved online to ensure access to the 
psycho-educational material any time later. All DT/PLs that were (partly) completed by 
patients were registered for study purposes. Program content was fixed during the 12 
weeks. Patients could contact the research psychologist (telephone/e-mail) to discuss any 
questions and/or problems.  
The content of the ENCOURAGE program was based on contemporary scientific 
literature and input from a multidisciplinary team of psychologists, oncology nurses, medical 
oncologists, a pastoral worker and a patient advocate. Breast cancer patients within 9 months 
after chemotherapy completion from the UMCG (N=12) evaluated the content of the program 
positively in terms of usefulness (Cohen’s d=0.30), feeling informed (0.66) and increased 
optimism and control over the future (0.96) in a small single arm pilot study compared to 
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 Patients assigned to the intervention group, had access to the program during 12 
subsequent weeks. An e-mail was sent to patients containing a leaflet that introduced the 
ENCOURAGE program together with log-in information. Patients were requested to visit the 
program and to complete the online DT/PL at least once during the first 7 days after 
receiving login information to ensure that all participants received some amount of 
psycho-educational material. The research psychologist contacted patients that had not 
accessed the program within the first week (a reminder mail was send, after 2 weeks they 
received a telephone call). No further use requests were imposed.  
 Standard care consisted of regular visits to a medical specialist (medical, surgical or 
radiation oncologist and/or oncology nurse) every 3 or 4 months during the first follow-up 
year. Patients were referred to additional health care by their oncologist and/or oncology 
nurse in case of unmet needs and/or a referral wish. 
 
Measures 
At baseline (T0), patient characteristics, health care use, distress and quality of life were 
assessed. At 6 (T1) and 12 weeks (T2) optimism and control over the future, feeling 
informed and acceptance of the illness, were measured. At 12 weeks (T2) patients’ 
health care use, distress and quality of life were re-assessed. At T2, the intervention group 
also received a  questionnaire regarding website opinion and use (T2).  
A self-report questionnaire was used to assess socio-demographic characteristics. 
Illness-related characteristics and treatment received were collected from patients’ medical 
records. The questionnaire also asked whether psychosocial and/or paramedical health care 
had been used before breast cancer diagnosis, after diagnosis and/or during study enrollment.  
 Increased optimism and control over the future’ (primary outcome) is an 8-item 
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Outcomes’ (CEO) questionnaire [26]. This questionnaire is developed and tested in 
various online support groups including breast cancer patients [27,28]. The subscales 
‘feel better informed’ (4 items; alpha=0.94; alpha=0.94) and ‘improved acceptance of the 
illness’ (5 items; alpha=0.92; alpha=0.94) were also measured. The questionnaire assesses 
retrospectively to what extent patients experience certain outcomes by their participation in an 
online support group. We changed ‘online support group’ into ‘website’ and ‘information 
leaflets’ for the intervention and control group, respectively. All items began with the 
statement: ‘Through the use of the website/information leaflets…’. Patients could answer on a 
5-point scale ranging from ‘completely disagree’ (1) to ‘completely agree’ (5). For each 
subscale a mean total score was calculated. Total scores were not calculated for the CEO 
questionnaire as the subscales measure heterogeneous constructs [27]. 
Distress was measured using the Dutch DT/PL [25,29]. The DT consists of a single 
item that asks patients to indicate the amount of distress experienced during the past week on 
an 11-point scale (0-10; no to extreme distress). On the 47-item PL, patients could indicate 
whether or not (yes/no) they experienced certain problems. Patients were asked to rate from 1-
10 the amount of distress they experienced for each item in the PL they answered ‘yes’. 
Lastly, the questionnaire measures patients’ referral wish (yes, maybe or no) to a health care 
professional. 
Quality of Life (QoL) was measured using the EORTC QLQ-C30, version 3.0 [30] 
and the QLQ-BR23 [31]. Global health status/QoL and the functional scales of these 
questionnaires (physical, role, cognitive, emotional, social functioning and body image, 
sexual functioning, sexual enjoyment and future perspective) were included.  
 The Technology Acceptance Model (TAM) questionnaire [32] was used to assess 
patients’ opinion of the ENCOURAGE program. The subscales ‘perceived usefulness’ (3 
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Items are rated on a 5-point Likert scale, ranging from ‘completely disagree’ (1) to 
‘completely agree’ (5). At the end of the questionnaire, patients had the opportunity to 




Data analysis  
The power analysis was performed on the difference for the mean subscale score of ‘increased 
optimism and control over the future’ between the control and intervention group at 12 weeks 
(T2). We aimed to recruit 128 patients (64 in each group) to detect a medium effect size of 
0.50 using a two-tailed test (β=0.80; α=0.05 (G*power [34])). Recruitment continued until 
128 patients returned the T2 questionnaire. 
The range of missing values was 0.0%-13.8% for all variables except for distress at 
T2. This variable had 24.6% missing values. Missing data patterns were examined and 
subsequently multiple imputed (20 imputations) by use of the fully conditional specification 
algorithm [35,36]. The results of the complete case analyses were similar to the results of the 
imputed datasets (N=138). Therefore, we decided to report the results based on the analyses 
of the original data. 
Descriptive statistics were calculated for socio-demographic and illness-related 
characteristics, CEO scales, TAM scales, QoL, the DT/PL and health care use. Analyses were 
performed according to the intention-to-treat principle. Separate ANCOVAs were performed 
to examine the effect of study group on the CEO scales and on changes in the DT/PL and 
QoL domains from baseline to T2. Differences between the study groups in patient 
characteristics, health care use and/or baseline measures were included as covariates in the 
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breast cancer patients. Patients were defined as clinically distressed with a baseline DT score 
≥5 [25,37]. These subgroup analyses were unplanned and therefore, underpowered. If 
standardized residuals of the ANCOVA model were non-normally distributed, the outcome 
variable was dichotomized (stable/improved scores versus worsened scores) and analyzed by 
a logistic regression analysis. Effect sizes were calculated by Cohen’s d for independent 
groups (mean unadjusted difference between the study groups divided by the pooled standard 




Of the approached 207 patients, 139 were enrolled in the study between January 2013 and 
October 2014. Figure 1 displays the CONSORT diagram. Patients not interested to participate 
most often reported that they were too busy or did not want to be confronted with cancer-
related information. Characteristics of the patients in the control and the intervention group 
are provided in Table 1. Less patients in the control group received immunotherapy during the 
study period than patients in the intervention group (χ2=4.0, P=.047). No differences between 
study completers and dropouts were observed for the baseline measures. 
 
Use and evaluation of the ENCOURAGE program 
According to the log files, two patients never visited the program. One of these patients 
returned the questionnaires and the intention-to-treat principle was applied. Eighteen 
patients did not log in within 1 week and were reminded by e-mail. Seven patients 
received an additional phone call as they had not logged in after 2 weeks. These contacts 
focused on program access and support was only provided for technical issues. The 
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61% of the patients logging in more than once. Self-reported use of the program was 
similar to this usage statistic (range 0-6; median=2; N=62).  
The mean score patients assigned to the usefulness of the program was 3.55 (SD=0.89; 
N=59). Of the patients, 71% agreed (score=4) or completely agreed (score=5) with having a 
positive attitude towards the program. Ten percent was not satisfied with the program.  
Three patients contacted the research psychologist to discuss problems and/or 
health care needs. The number of problems reported on the online DT/PLs ranged from 0 to 
30 (M=14; SD=6). Psycho-education was provided most often (89x) for ‘lack of physical 
fitness’ (73% of total number of completed PLs)), ‘fatigue’ (71%), ‘problems with 
appearance’ (56%), ‘tingling in hands/feet’ (55%) and ‘lack of muscle strength’ (55%).   
 
Primary and secondary outcomes 
No significant difference was detected in ‘increased optimism and control over the future’ at 
T2 between the control and the intervention group. Also, no effects were detected for the 
primary outcome at T1. Patients in the control group reported higher scores for ‘being better 
informed’ and ‘increased acceptance’ than patients in the intervention group at T1. At T2, no 
differences between the study groups for these outcomes were obtained (Table 2). Both study 
groups improved equally well between T1 and T2 regarding ‘increased optimism and control 
over the future’, ‘being better informed’, and ‘increased acceptance’. Improvements in 
distress, distress-related problems and QoL were observed in both study groups but no 
significant differences were observed between the groups at T2 (Table 3).   
 
Distressed breast cancer patients 
Several patients reported that they did not felt supported by the ENCOURAGE program since 
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decided to analyze the 57 (41%) clinically distressed patients separately (N=21 in the 
intervention group, N=26 patients in the control group, N=10 missing data at T2).  
Usefulness of the program was rated with a 3.75 (SD=0.75; N=21). Seventeen of 21 
distressed patients (81%) randomized in the intervention group agreed or completely agreed 
with having a positive attitude towards the program. More distressed patients in the 
intervention group (15%) than in the control group (38%) received radiotherapy during the 
study period (χ2=3.15, p=0.076, N=47). 
The clinically distressed patients in the intervention group reported a higher increase 
in optimism and control over the future at T2 than the patients in the control group (Table 2). 
Additionally, in the intervention group (Mchange=0.25), but not in the control group 
(Mchange=0.02), ‘increased optimism and control over the future’ improved from T1 to T2 
(95% CI=0.06-0.58, F(1,40)=6.31, P=.016, Cohen’s d=0.51). No between-group effects 
were observed for the secondary outcomes (Table 3). 
 
Discussion 
This study was among the first that evaluated the effects of a web-based tailored psycho-
educational intervention for breast cancer patients in the re-entry phase. Although results 
showed no harmful effects of the ENCOURAGE program, no additional beneficial effects of 
the program compared to the information leaflets that are part of standard care, were 
observed.  
An explanation for the absence of effects may be that certain patients could not further 
increase in optimism and control over the future. For example, patients who suffer from minor 
symptoms may not experience an increase herein after use of the program as they feel that 
their symptoms are already in control. Thus, the program may be effective for a subgroup of 
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feelings of optimism and control over the future more than standard care in the subgroup of 
patients with clinically elevated distress at baseline. This might imply that distressed patients 
benefit from such a web-based program. About 30-60% of breast cancer patients suffer from 
clinically elevated distress during the first 6 months after treatment completion [38]. 
Similarly, we found 41% of the breast cancer patients to be distressed at baseline of the study. 
If the program is of help to distressed patients, a relatively large patient population may 
benefit from the use of the ENCOURAGE program. However, this is a premature conclusion 
and the results of the subgroup analyses should be interpreted with caution as they were 
unplanned and underpowered.  
 
Methodological considerations 
The absence of findings may, in part, be explained by the design of the program and the 
intervention onset. Considering the rather low program use, patients may have been exposed 
too little to the content of the program to solicit any observable effect. The ENCOURAGE 
program adopted a problem-solving orientation. Problem solving therapy (PST) 
includes the elements: problem orientation, problem definition, generation of 
alternatives, decision-making, solution implementation and verification that should be 
stepwise addressed [18]. Our program incorporated problem orientation and problem 
definition but the other elements were only implicitly addressed in the psycho-
educational material. About 10 sessions are recommended to deliver an effective PST 
intervention [18,19]. During the 12-week access to the program, patients were not 
guided throughout all the PST phases, probably contributing to the absence of effects. 
Future research with the ENCOURAGE program should incorporate all PST phases 
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tested in distressed patients, immediately after completion of chemotherapy to ensure 
that survivors receive support at an early phase.  
Positive adjustment questionnaires, like the CEO questionnaire, are scarce. This 
questionnaire suited the purposes of the current study: it was specially developed to 
assess outcomes by the use of web-based programs and was tested in breast cancer 
patients. However, as baseline scores could not be derived due to its retrospective nature 
and it is not extensively validated, it might lack sensitivity to measure change.  
Several strengths can be noted. The current RCT evaluated a web-based psycho-
educational program that targets a gap in survivorship care wherein breast cancer patients 
report high unmet needs [1,6]. At present, very few of such programs are available. The 
study was conducted in line with the CONSORT statement for reporting eHealth interventions 
[39,40]. The included patients varied in socio-demographic and illness-related 
characteristics and distress reflecting the representativeness of the current sample.  
 
Conclusion 
In contrast to our expectations, no effects in favor of the ENCOURAGE program were 
observed. Given the findings that especially distressed patients evaluated the program 
positively, a subgroup of breast cancer patients might benefit from this intervention. We aim 
to further develop and test the program. The valuable information of the current study 
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CONSORT diagram of patient flow from patient approach to analyses.  
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N M±SD N M±SD P 
Age (years) 
 
69 53.2±8.5 69 53.1±9.8 .920 
Time since diagnosis  
(months)     
69   8.7±1.9 69    8.7±2.1 .920 
Time since chemotherapy 
(months) 
69    2.4±1.7 69    1.9±1.5 .078 
 C I  
 N % N % P 
Marital status  
   Married/living together 















   Yes 













Children at home 
   Yes 















   Lower vocational 
   Secondary education/higher general 



















   Yes 












Cancer stage  
   I 
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   III 35 51 36 52 
Breast cancer type 
   IDC 
   ILC 















   Lumpectomy 














Cancer treatment during study      
   Cosmetic surgerya 
      Yes 










   Radiotherapya 
      Yes 










   Immunotherapya 
      Yes 










   Hormone therapy 
      Yes 










Health care use      
   Before diagnosis 
      Yes 










   After diagnosis 
      Yes 










   During study 
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      No 21 33 29 46 
M=mean; SD=standard deviation; I=intervention group; C=control group; ns=non-significant 
Indepent-samples t-tests (continuous variables) and Χ2 tests (categorical variables) were  




















Group means and differences for empowering outcomes for the control and intervention group. 
M=mean; SD=standard deviation; C=control group; I=intervention group; ES=effect size 







 At 6 weeks (T1)      At 12 weeks (T2) 
    
 C I Group differences  C I Group differences 
 CEO subscale M±SD N M±SD N I – C (95% CI)ab Pab ES  M±SD N M±SD N I – C (95% CI)ab Pab ES 
Complete sample                
    Increased optimism and control 3.09±0.54 61 3.14±0.50 58 0.06 (-0.13, 0.26)  .515 0.11  3.10±0.57 61 3.18±0.52 59  0.10 (-0.10, 0.30) .312 0.15 
    Being better informed 3.73±0.57 60 3.39±0.82 58 -0.31 (-0.57, -0.05)   .020 0.48  3.56±0.65 62 3.31±0.86 60 -0.24 (-0.52, 0.04) .088 0.33 
    Improved acceptance 3.09±0.88 61 2.78±0.79 58 -0.32 (-0.63, -0.01)  .044 0.37  3.04±0.90 62 2.73±0.88 60 -0.26 (-0.58, 0.06) .114 0.35 
                
Distressed patients                
  Increased optimism and control 3.03±0.59 26 3.10±0.61 22 0.08 (-0.28, 0.44) .666 0.11  2.97±0.57 26 3.34±0.59 21   0.43 (0.85, 0.78)  .017 0.65 
    Being better informed 3.69±0.65 25 3.44±0.90 22 -0.27 (-0.74, 0.20)  .246 0.31  3.49±0.69  27 3.38±0.86 22 -0.13 (-0.62, 0.35) .584 0.15 


















Group means and differences for distress, distress-related problems and QoL for the control and intervention group. 
 Baseline (T0)  ∆12 weeks (T2) 
    
 C  I  C I  Group differences 
Outcome M±SD N M±SD N  M±SD M±SD  ∆ I - C (95% CI) ab Pab ES 
Complete sample            
 Distress           
 
    DT  4.65±2.00 51 3.82±2.24 49  -0.59±2.55 -0.20±2.15  -0.02 (-0.91, 0.87) .964 0.16 
    Problem domains            
       Practical     0.74 ±0.96 63 0.81±1.05 61  -0.16±1.03 -0.25±1.16  0.96 (0.39, 2.38)c .936  
       Social         0.30±0.99 62 0.51±1.09 62  0.04±1.22 -0.27±0.84  5.08 (0.49, 52.58)c .173  
       Emotional  1.38±1.30 58 1.48±1.72 58  -0.08±1.32 -0.34±1.41  -0.27 (-0.68, 0.14) .190 0.19 
       Spiritual     0.52±1.31 61 0.54±1.48 61  -0.24±1.19 -0.37±1.11  0.76 (0.11, 5.39)c .787  
       Physical     1.53±1.18 60 1.45±1.15 57  -0.64±1.02 -0.58±1.01  -0.06 (-0.28, 0.16) .588 0.06 
QoL – EORTC-C30            
   Global health status/QoL 67.46±18.74 63 68.55±17.56 62  5.95±17.67 5.78 ±19.42  0.90 (-4.33, 6.12) .735 0.01 
   Functional scales  
 
         
      Physical 76.83±16.76 63 79.68±17.64 62  9.21±13.52 6.42±15.33  -0.61 (-4.42, 3.21) .754 0.19 
      Role 63.23±27.62 63 66.94±29.18 62  11.11±25.92 9.68±25.53  2.44 (-4.70, 9.57) .500 0.06 

















      Cognitive 75.93±18.64 63 79.37±21.53 63  5.03±14.86 3.97±20.02  2.28 (-2.77, 7.33) .374 0.06 
      Social 76.19±27.55 63 77.96±22.34 62  8.47±25.38 11.02±20.46  4.24 (-1.63, 10.10) .155 0.11 
QoL – BR23            
   Body image 77.42±22.55 62 69.53±25.77 64  5.11±15.63 11.46±23.03  2.91 (-3.05, 8.78) .335 0.32 
   Sexual functioning 20.43±21.00 62 14.41±18.94 59  6.45±15.78 8.47±15.59  0.52 (-4.93, 5.98) .850 0.13 
   Sexual Enjoyment 60.26±24.98 26 45.00±31.11 20  5.13±22.49 10.00±21.90  -0.46 (-12.47, 11.56) .940 0.22 
   Future perspective 66.67±25.61 62 60.42±25.11 64  0.54±22.17 5.73±25.58  3.94 (-3.69, 11.57) .309 0.22 
            
Distressed subgroup            
 Distress           
 
    DT  6.46±1.22 24 6.50±1.37 16  -1.67±2.53 -1.19±1.42  0.14 (-1.24, 1.53) .835 0.23 
    Problem domains         
  
 
       Practical     1.14±1.18 28 1.51±1.23 23  -0.35±1.27 -0.66±1.36  0.93 (0.22, 3.94)c .916  
       Social         0.83±1.33 27 0.97±1.52 23  -0.02±1.83 -0.61±0.99  
  2.76 (0.15, 47.20)c .503  
       Emotional  1.99±1.43 24 2.80±1.94 22  -0.57±1.51 -1.20±1.78  -0.36 (-1.16, 0.45) .374 0.38 
       Spiritual     1.06±1.82 27 1.27±2.21 22  -0.67±1.52 -0.86±1.59  
   1.08 (0.08, 14.24)c .952  
       Physical     2.06±1.18 27 2.21±1.16 22  -1.03±1.01 -1.09±1.26  0.21 (-0.40, 0.44) .919 0.05 
QoL – EORTC-C30         
  
 

















   Functional scales         
  
 
      Physical 69.29±17.90 28 67.25±18.08 23  13.57±15.45 12.46±15.35  -2.05 (-9.09, 4.99) .561 0.07 
      Role 54.17±29.62 28 47.83±30.69 23  17.26±26.25 17.39±23.83  -3.38 (-15.45, 8.68) .575 0.00 
      Emotional 72.32±19.78 28 67.39±24.22 23  5.56±19.47 10.14±24.87  4.38 (-5.31, 14.06) .368 0.21 
      Cognitive 73.81±18.94 28 70.29±25.60 23  8.33±14.70 12.32±22.60  3.28 (-5.88, 12.43) .475 0.21 
      Social 62.50±32.27 28 63.04±21.29 23  17.26±32.55 21.74±20.98  5.03 (-7.20, 17.26) .412 0.16 
QoL – BR23         
  
 
   Body image 71.91±24.04 27 57.61±26.34 23  6.48±17.19 19.93±27.61  6.65 (-5.22, 18.51) .265 0.58 
   Sexual functioning 17.28±21.92 27 18.18±21.15 22  9.26±18.68 9.09±16.04  0.64 (-9.23, 10.51) .897 0.00 
   Sexual Enjoyment 62.50±27.82 8 43.33±31.62 10  8.33±29.55 16.67±23.57  -0.75 (-24.85, 23.34) .948 0.31 
   Future perspective 58.02±25.47 27 46.38±31.36 23  2.47±22.51 15.94±26.34  11.10 (-2.31, 24.50) .103 0.55 
M=mean; SD=standard deviation; C=control group; I=intervention group; ES=effect size 
aComplete sample=adjusted for the variable ‘receiving current immunotherapy’; bDistressed patients=adjusted for the variable ‘receiving current 
radiotherapy’ 
cLogistic regression: Exp(B) and 95% CI for Exp(B) are displayed 
 
 
 
